For anaerobic intra-abdominal infections, what is a classic first-line agent?

Prepare for the Antibacterials (ABX) Exam. Study with flashcards and multiple-choice questions, each question comes with hints and explanations. Get ready to ace your test!

Multiple Choice

For anaerobic intra-abdominal infections, what is a classic first-line agent?

Explanation:
Anaerobic coverage is essential in intra-abdominal infections because the gut flora includes robust anaerobes that drive disease. Metronidazole provides strong, reliable activity against these anaerobes, including Bacteroides fragilis, Fusobacterium, and Clostridium species, making it a classic first-line option. Its mechanism—activation in anaerobic environments to DNA-damaging radicals—explains its selective potency against anaerobes while sparing aerobic bacteria. It also penetrates well into infected tissue and abscesses, helping eradicate the anaerobic component of the infection. Since intra-abdominal infections are often polymicrobial, metronidazole is commonly paired with another agent that covers aerobic bacteria, providing broad coverage. Other agents either lack reliable anaerobic activity against these gut organisms or do not cover the anaerobic pathogens as robustly as metronidazole.

Anaerobic coverage is essential in intra-abdominal infections because the gut flora includes robust anaerobes that drive disease. Metronidazole provides strong, reliable activity against these anaerobes, including Bacteroides fragilis, Fusobacterium, and Clostridium species, making it a classic first-line option. Its mechanism—activation in anaerobic environments to DNA-damaging radicals—explains its selective potency against anaerobes while sparing aerobic bacteria. It also penetrates well into infected tissue and abscesses, helping eradicate the anaerobic component of the infection. Since intra-abdominal infections are often polymicrobial, metronidazole is commonly paired with another agent that covers aerobic bacteria, providing broad coverage. Other agents either lack reliable anaerobic activity against these gut organisms or do not cover the anaerobic pathogens as robustly as metronidazole.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy